<DOC>
	<DOCNO>NCT01017029</DOCNO>
	<brief_summary>The purpose study , de novo heart transplant patient , evaluate whether delayed introduction everolimus reduces occurrence wound heal problem , pericardial and/or pleural effusion early acute renal insufficiency , compare immediate introduction everolimus , firs six month heart transplantation .</brief_summary>
	<brief_title>Everolimus de Novo Heart Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Inclusion criterion : Male female cardiac transplant candidate 1865 year age undergoing primary heart transplantation . Glomerular filtration rate ( GFR MDRD ) â‰¥ 40 mL/min/1.73 m2 randomization Exclusion criterion : Patients recipient multiple solid organ transplant Patients HIVpositive Hepatitis C positive ( PCR ) Bsurface antigen positive ; Presence Donor/Recipients serological mismatch Hepatitis B C ; Recipients organ donor positive Hepatitis Bsurface antigen ; Panel Reactive Antibodies ( cytotoxicity method ) &gt; 30 % . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>